J. Stern & Co. LLP Purchases 7,179 Shares of Xylem Inc. (NYSE:XYL)

J. Stern & Co. LLP boosted its position in shares of Xylem Inc. (NYSE:XYL) by 2.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 289,984 shares of the industrial products company’s stock after buying an additional 7,179 shares during the period. Xylem makes up about 4.7% of J. Stern & Co. LLP’s portfolio, making the stock its 11th biggest holding. J. Stern & Co. LLP’s holdings in Xylem were worth $39,331,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. EverSource Wealth Advisors LLC boosted its position in shares of Xylem by 68.8% during the 1st quarter. EverSource Wealth Advisors LLC now owns 189 shares of the industrial products company’s stock valued at $25,000 after acquiring an additional 77 shares during the last quarter. Mark Sheptoff Financial Planning LLC purchased a new position in shares of Xylem in the 2nd quarter worth $33,000. Blue Trust Inc. grew its stake in shares of Xylem by 1,185.7% in the 2nd quarter. Blue Trust Inc. now owns 270 shares of the industrial products company’s stock worth $35,000 after buying an additional 249 shares in the last quarter. FinTrust Capital Advisors LLC increased its holdings in shares of Xylem by 170.9% in the 1st quarter. FinTrust Capital Advisors LLC now owns 317 shares of the industrial products company’s stock worth $41,000 after buying an additional 200 shares during the last quarter. Finally, Hazlett Burt & Watson Inc. raised its position in shares of Xylem by 184.9% during the 1st quarter. Hazlett Burt & Watson Inc. now owns 339 shares of the industrial products company’s stock valued at $43,000 after buying an additional 220 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Stock Performance

Shares of Xylem stock opened at $134.81 on Monday. Xylem Inc. has a one year low of $87.59 and a one year high of $146.08. The company has a 50-day simple moving average of $133.68 and a two-hundred day simple moving average of $134.24. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.33 and a current ratio of 1.85. The company has a market capitalization of $32.68 billion, a PE ratio of 47.98, a P/E/G ratio of 2.34 and a beta of 1.04.

Xylem (NYSE:XYL) last released its earnings results on Tuesday, July 30th. The industrial products company reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.05 by $0.04. Xylem had a net margin of 9.11% and a return on equity of 9.48%. The company had revenue of $2.17 billion during the quarter, compared to analysts’ expectations of $2.14 billion. During the same period last year, the business earned $0.98 EPS. Xylem’s revenue for the quarter was up 26.0% on a year-over-year basis. Research analysts expect that Xylem Inc. will post 4.26 EPS for the current fiscal year.

Xylem Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 26th. Stockholders of record on Thursday, August 29th will be issued a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.07%. The ex-dividend date of this dividend is Thursday, August 29th. Xylem’s dividend payout ratio (DPR) is presently 51.25%.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on XYL shares. Argus boosted their price objective on Xylem from $146.00 to $165.00 and gave the stock a “buy” rating in a research note on Wednesday, May 29th. Royal Bank of Canada boosted their target price on Xylem from $160.00 to $163.00 and gave the company an “outperform” rating in a research report on Wednesday, July 31st. Oppenheimer raised their price target on Xylem from $147.00 to $152.00 and gave the stock an “outperform” rating in a research report on Friday, May 31st. Stifel Nicolaus boosted their price objective on shares of Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a research report on Wednesday, July 31st. Finally, TD Cowen restated a “hold” rating and issued a $138.00 target price on shares of Xylem in a report on Tuesday, September 3rd. Five equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat, Xylem presently has an average rating of “Moderate Buy” and a consensus target price of $147.54.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.